Eva Renee Barnett Immunovant, Inc. (IMVT) insider trading activity

IMVT Quotes by TradingView

Eva Renee Barnett is Chief Financial Officer of Immunovant, Inc.. Currently has a direct ownership of 396,774 shares of IMVT, which is worth approximately $10.9 Million. The most recent transaction as insider was on Aug 17, 2022, when has been sold 112,816 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 397K
22.17% 3M change
10.38% 12M change
Total Value Held $10.9 Million

Eva Renee Barnett Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 17 2022
BUY
Grant, award, or other acquisition
-
112,816 Added 28.33%
285,357 Common Stock
Jan 07 2022
SELL
Open market or private sale
$217,203 $7.25 p/Share
29,959 Reduced 14.79%
172,541 Common Stock
Oct 15 2021
BUY
Grant, award, or other acquisition
-
143,000 Added 41.39%
202,500 Common Stock
Oct 04 2021
BUY
Grant, award, or other acquisition
-
59,500 Added 50.0%
59,500 Common Stock
ERB

Eva Renee Barnett

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on IMVT

Follow Immunovant, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

News

Receive news related to Immunovant, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMVT